Live feed
Filing
SC 13D/A
SC 13D/A0001104659-20-128504·Avista Capital Partners III GP, L.P.
Schedule 13D ownership disclosure
RVL PHARMACEUTICALS PLC
Security class unavailable · CUSIP: G6S41R101
Event date: 2020-11-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,032,995
- Percent of class
- 1.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-128504
- Form type
- SC 13D/A
- Filer
- Avista Capital Partners III GP, L.P.
- CIK
- CIK 1705722
- Filed
- Nov 23, 2020
- Reporting period
- Nov 20, 2020
- Description
- Schedule 13D beneficial ownership